About Acadia Healthcare Company (NASDAQ:ACHC)
Acadia Healthcare Company, Inc. is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities. The Company is engaged in operating acute inpatient psychiatric facilities, specialty treatment facilities, residential treatment centers and facilities providing outpatient behavioral healthcare services. As of December 31, 2016, the U.S. Facilities segment included 208 behavioral healthcare facilities with approximately 8,500 beds in 39 states and Puerto Rico, and the U.K. Facilities segment included 365 behavioral healthcare facilities with approximately 8,600 beds in the United Kingdom. As of December 31, 2016, the Company had operated 573 behavioral healthcare facilities with approximately 17,100 beds in 39 states, the United Kingdom and Puerto Rico.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Healthcare Facilities & Services
- Sub-Industry: Health Care Facilities
- Symbol: NASDAQ:ACHC
- CUSIP: 00404A10
- Web: www.acadiahealthcare.com
Capitalization:- Market Cap: $3.6664 billion
- Outstanding Shares: 87,870,000
Average Prices:- 50 Day Moving Avg: $46.12
- 200 Day Moving Avg: $46.36
- 52 Week Range: $32.54 - $54.34
P/E:- Trailing P/E Ratio: 456.70
- Foreward P/E Ratio: 14.74
- P/E Growth: 1.34
Sales & Book Value:- Annual Revenue: $2.83 billion
- Price / Sales: 1.29
- Book Value: $27.32 per share
- Price / Book: 1.52
Profitability:- EBITDA: $574.61 million
- Net Margins: 0.30%
- Return on Equity: 8.69%
- Return on Assets: 3.16%
Debt:- Debt-to-Equity Ratio: 1.36%
- Current Ratio: 1.32%
- Quick Ratio: 1.32%
Misc:- Average Volume: 1.00 million shs.
- Beta: 1.07
- Short Ratio: 22.75
Frequently Asked Questions for Acadia Healthcare Company (NASDAQ:ACHC)
What is Acadia Healthcare Company's stock symbol?
Acadia Healthcare Company trades on the NASDAQ under the ticker symbol "ACHC."
How were Acadia Healthcare Company's earnings last quarter?
Acadia Healthcare Company, Inc. (NASDAQ:ACHC) released its quarterly earnings data on Thursday, July, 27th. The company reported $0.66 EPS for the quarter, topping analysts' consensus estimates of $0.65 by $0.01. The company earned $715.90 million during the quarter, compared to the consensus estimate of $717.38 million. Acadia Healthcare Company had a net margin of 0.30% and a return on equity of 8.69%. The firm's revenue for the quarter was down 5.4% compared to the same quarter last year. During the same period last year, the firm earned $0.73 EPS. View Acadia Healthcare Company's Earnings History.
When will Acadia Healthcare Company make its next earnings announcement?
What guidance has Acadia Healthcare Company issued on next quarter's earnings?
Acadia Healthcare Company issued an update on its FY17 earnings guidance on Thursday, July, 27th. The company provided EPS guidance of $2.42-2.47 for the period, compared to the Thomson Reuters consensus estimate of $2.45. The company issued revenue guidance of $2.85-2.87 billion, compared to the consensus revenue estimate of $2.87 billion.
Where is Acadia Healthcare Company's stock going? Where will Acadia Healthcare Company's stock price be in 2017?
12 analysts have issued 12-month price objectives for Acadia Healthcare Company's shares. Their predictions range from $45.00 to $65.00. On average, they anticipate Acadia Healthcare Company's share price to reach $56.60 in the next year. View Analyst Ratings for Acadia Healthcare Company.
What are analysts saying about Acadia Healthcare Company stock?
Here are some recent quotes from research analysts about Acadia Healthcare Company stock:
- 1. According to Zacks Investment Research, "Shares of Acadia Healthcare outperformed the industry year to date. The company suffers from high debt, escalating interest expenses and foreign exchange fluctuation. Substantial integration risks associated with its frequent acquisitions are major headwinds. The company is, however, well positioned for long-term growth on the back of its inorganic strategies. Its latest Priory acquisition has substantially enhanced its asset base, making it the largest independent provider of mental health services in the U.K. Its mixed product portfolio has helped in intensifying business risk. The company’s strong balance sheet, with increasing cash flow is another positive." (10/12/2017)
- 2. Cantor Fitzgerald analysts commented, "ACHC’s weak 1Q17 organic growth and a slight revenue and adjusted EBITDA miss are measured against tough comps, which continue in 2Q17, but ease in the second half, assuming no further decline in the pound. Volumes, up 5.8%, were okay in the U.S., but essentially flat overseas, and 2Q16, when organic growth was also strong, could be a tough comparison." (4/26/2017)
Are investors shorting Acadia Healthcare Company?
Acadia Healthcare Company saw a decrease in short interest during the month of September. As of September 29th, there was short interest totalling 17,773,953 shares, a decrease of 14.3% from the September 15th total of 20,744,872 shares. Based on an average daily volume of 654,559 shares, the days-to-cover ratio is currently 27.2 days. Approximately 21.0% of the shares of the company are sold short.
Who are some of Acadia Healthcare Company's key competitors?
Some companies that are related to Acadia Healthcare Company include NMC Health PLC (NMC), HealthSouth Corporation (HLS), Mednax (MD), Chemed Corp. (CHE), Select Medical Holdings Corporation (SEM), Udg Healthcare PLC (UDG), LifePoint Health (LPNT), HMS Holdings Corp (HMSY), Tenet Healthcare Corporation (THC), China Cord Blood Corporation (CO), HealthStream (HSTM), Community Health Systems (CYH), Kindred Healthcare (KND), Georgia Healthcare Group PLC (GHG), American Renal Associates Holdings (ARA), Cambian Group PLC (CMBN), Concord Medical Services Holdings Limited (CCM) and Nobilis Health Corp (HLTH).
Who are Acadia Healthcare Company's key executives?
Acadia Healthcare Company's management team includes the folowing people:
- Joey A. Jacobs, Chairman of the Board, Chief Executive Officer
- W. Brent Turner, President
- Bruce A. Shear, Executive Vice Chairman
- David M. Duckworth, Chief Financial Officer
- Ronald Morgan Fincher, Chief Operating Officer
- Christopher L. Howard, Executive Vice President, General Counsel, Secretary
- Reeve B. Waud Jr., Lead Independent Director
- E. Perot Bissell, Independent Director
- Christopher R. Gordon, Independent Director
- Vicky B. Gregg, Independent Director
Who owns Acadia Healthcare Company stock?
Acadia Healthcare Company's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include
BAIN CAPITAL FUND VIII, LLC
(1.00%). Company insiders that own Acadia Healthcare Company stock include Brent Turner, Christopher L Howard, Danny E Carpenter, David M Duckworth, Joey A Jacobs, Randall P Goldberg, Reeve B Waud, Ronald Morgan Fincher, Scott Schwieger, Waud Capital Partners Ii, LL, Waud Capital Partners Iii, LL and William Grieco. View Institutional Ownership Trends for Acadia Healthcare Company.
How do I buy Acadia Healthcare Company stock?
Shares of Acadia Healthcare Company can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Acadia Healthcare Company's stock price today?
One share of Acadia Healthcare Company stock can currently be purchased for approximately $41.56.
MarketBeat Community Rating for Acadia Healthcare Company (NASDAQ ACHC)MarketBeat's community ratings are surveys of what our community members think about Acadia Healthcare Company and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for Acadia Healthcare Company (NASDAQ:ACHC) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 2 Hold Ratings, 9 Buy Ratings, 1 Strong Buy Rating |
| Consensus Rating: | Buy (Score: 2.92) |
| Consensus Price Target: | $56.60 (36.19% upside) |
Consensus Price Target History for Acadia Healthcare Company (NASDAQ:ACHC)
Analysts' Ratings History for Acadia Healthcare Company (NASDAQ:ACHC)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 10/16/2017 | BMO Capital Markets | Initiated Coverage | Outperform | $52.00 | N/A |  |
| 10/11/2017 | Jefferies Group LLC | Set Price Target | Buy | $60.00 | N/A | |
| 7/31/2017 | Deutsche Bank AG | Boost Price Target | Buy | $58.00 -> $60.00 | Low | |
| 7/31/2017 | Craig Hallum | Reiterated Rating | Buy | $52.00 -> $65.00 | Low | |
| 7/28/2017 | Mizuho | Boost Price Target | Buy | $57.00 -> $60.00 | Low | |
| 7/18/2017 | William Blair | Initiated Coverage | Outperform -> Outperform | | Low | |
| 6/1/2017 | KeyCorp | Reiterated Rating | Overweight | $51.00 | Low | |
| 5/15/2017 | Leerink Swann | Downgrade | Outperform -> Market Perform | | Medium | |
| 4/26/2017 | Cantor Fitzgerald | Reiterated Rating | Hold | $45.00 | High | |
| 3/6/2017 | Citigroup Inc. | Boost Price Target | Buy | $43.00 -> $52.00 | N/A | |
| 1/3/2017 | Royal Bank Of Canada | Reiterated Rating | Buy | $56.00 | N/A | |
| 11/3/2016 | Raymond James Financial, Inc. | Upgrade | Outperform -> Strong-Buy | $65.00 | N/A | |
| 9/27/2016 | J P Morgan Chase & Co | Reiterated Rating | Hold | $61.00 | N/A | |
| 9/15/2016 | Robert W. Baird | Lower Price Target | Outperform | $67.00 -> $66.00 | N/A | |
| 2/20/2016 | Stephens | Reiterated Rating | Buy | | N/A | |
| 2/18/2016 | Susquehanna Bancshares Inc | Lower Price Target | Positive | $92.00 -> $75.00 | N/A | |
| 2/17/2016 | Avondale Partners | Lower Price Target | Market Outperform | $90.00 -> $71.00 | N/A | |
(Data available from 10/17/2015 forward)
Earnings History for Acadia Healthcare Company (NASDAQ:ACHC)Earnings History by Quarter for Acadia Healthcare Company (NASDAQ ACHC)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 10/30/2017 | | $0.66 | | | | | N/A | |
| 7/27/2017 | Q2 2017 | $0.65 | $0.66 | $717.38 million | $715.90 million | View | N/A | |
| 4/25/2017 | Q1 2017 | $0.46 | $0.46 | $691.74 million | $679.20 million | View | N/A | |
| 2/23/2017 | Q416 | $0.55 | $0.59 | $708.41 million | $702.89 million | View | Listen | |
| 11/1/2016 | Q3 | $0.59 | $0.58 | $735.59 million | $789.40 million | View | Listen | |
| 7/29/2016 | Q216 | $0.73 | $0.73 | $752.57 million | $756.50 million | View | Listen | |
| 4/28/2016 | Q1 | $0.54 | $0.55 | $612.77 million | $616.80 million | View | Listen | |
| 2/16/2016 | Q4 | $0.59 | $0.59 | $488.00 million | $495.30 million | View | Listen | |
| 11/3/2015 | Q315 | $0.57 | $0.62 | $7.63 million | $479.70 million | View | Listen | |
| 8/4/2015 | Q215 | $0.52 | $0.57 | $433.84 million | $453.70 million | View | Listen | |
| 4/28/2015 | Q115 | $0.41 | $0.43 | $356.21 million | $365.80 million | View | Listen | |
| 2/11/2015 | Q414 | $0.46 | $0.46 | $296.20 million | $294.90 million | View | Listen | |
| 10/29/2014 | Q214 | $0.41 | $0.46 | $284.31 million | $294.50 million | View | Listen | |
| 7/29/2014 | Q114 | $0.31 | $0.58 | $207.73 million | $213.80 million | View | Listen | |
| 4/29/2014 | Q413 | $0.28 | $0.28 | $194.83 million | $206.10 million | View | Listen | |
| 2/28/2014 | Q313 | $0.29 | $0.29 | $189.56 million | $190.00 million | View | Listen | |
| 10/30/2013 | | $0.27 | $0.29 | $179.47 million | $184.70 million | View | Listen | |
| 7/30/2013 | Q2 2013 | $0.25 | $0.26 | $169.21 million | $177.50 million | View | Listen | |
| 11/6/2012 | Q312 | $0.16 | $0.16 | $104.91 million | $103.10 million | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Acadia Healthcare Company (NASDAQ:ACHC)2017 EPS Consensus Estimate: $2.46
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2017 | 3 | $0.45 | $0.48 | $0.47 |
| Q2 2017 | 5 | $0.64 | $0.67 | $0.66 |
| Q3 2017 | 5 | $0.64 | $0.68 | $0.66 |
| Q4 2017 | 4 | $0.66 | $0.68 | $0.67 |
(Data provided by Zacks Investment Research)
Dividend History for Acadia Healthcare Company (NASDAQ:ACHC)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Acadia Healthcare Company (NASDAQ:ACHC)Insider Ownership Percentage: 11.10%
Insider Trades by Quarter for Acadia Healthcare Company (NASDAQ:ACHC)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 8/22/2017 | Brent Turner | President | Sell | 206,252 | $50.69 | $10,454,913.88 | |
| 8/22/2017 | Christopher L Howard | EVP | Sell | 53,713 | $50.69 | $2,722,711.97 | |
| 8/22/2017 | Joey A Jacobs | CEO | Sell | 500,000 | $50.69 | $25,345,000.00 | |
| 8/22/2017 | Reeve B. Waud | Director | Sell | 984,075 | $50.69 | $49,882,761.75 | |
| 8/22/2017 | Ronald Morgan Fincher | COO | Sell | 80,000 | $50.69 | $4,055,200.00 | |
| 8/11/2017 | William Grieco | Director | Sell | 2,000 | $51.71 | $103,420.00 | |
| 8/3/2017 | Christopher L Howard | EVP | Sell | 16,762 | $52.47 | $879,502.14 | |
| 7/31/2017 | Reeve B. Waud | Director | Sell | 1,240,000 | $51.72 | $64,132,800.00 | |
| 7/31/2017 | Scott Schwieger | Insider | Sell | 2,891 | $52.85 | $152,789.35 | |
| 7/5/2017 | Reeve B. Waud | Director | Sell | 50,000 | $50.04 | $2,502,000.00 | |
| 6/22/2017 | Reeve B. Waud | Director | Sell | 50,000 | $47.51 | $2,375,500.00 | |
| 6/16/2017 | William Grieco | Director | Sell | 2,000 | $45.42 | $90,840.00 | |
| 6/14/2017 | Reeve B. Waud | Director | Sell | 724,694 | $45.53 | $32,995,317.82 | |
| 6/9/2017 | Reeve B. Waud | Director | Sell | 50,000 | $45.09 | $2,254,500.00 | |
| 5/4/2017 | Randall P Goldberg | VP | Sell | 4,925 | $45.18 | $222,511.50 | |
| 5/1/2017 | Ronald Morgan Fincher | COO | Sell | 86,483 | $44.43 | $3,842,439.69 | |
| 3/8/2017 | Randall P Goldberg | VP | Sell | 914 | $43.55 | $39,804.70 | |
| 12/16/2016 | Reeve B Waud | Director | Sell | 28,000 | $34.58 | $968,240.00 | |
| 12/14/2016 | Reeve B Waud | Director | Sell | 42,000 | $34.71 | $1,457,820.00 | |
| 12/13/2016 | Reeve B Waud | Director | Sell | 14,000 | $35.10 | $491,400.00 | |
| 12/12/2016 | Reeve B Waud | Director | Sell | 14,000 | $35.79 | $501,060.00 | |
| 9/16/2016 | Reeve B Waud | Director | Sell | 1,360,977 | $48.52 | $66,034,604.04 | |
| 9/16/2016 | Waud Capital Partners Iii, L.L | Major Shareholder | Sell | 457,443 | $48.39 | $22,135,666.77 | |
| 9/13/2016 | Reeve B Waud | Director | Sell | 84,208 | $51.71 | $4,354,395.68 | |
| 9/13/2016 | Waud Capital Partners Ii, L.L. | Major Shareholder | Sell | 54,254 | $51.71 | $2,805,474.34 | |
| 8/15/2016 | David M Duckworth | CFO | Sell | 16,670 | $54.33 | $905,681.10 | |
| 8/12/2016 | Ronald Morgan Fincher | COO | Sell | 14,604 | $52.50 | $766,710.00 | |
| 8/8/2016 | Ronald Morgan Fincher | COO | Sell | 8,800 | $52.56 | $462,528.00 | |
| 11/6/2015 | Danny E Carpenter | Major Shareholder | Sell | 15,000 | $74.02 | $1,110,300.00 | |
| 8/14/2015 | Bain Capital Investors Llc | Insider | Sell | 2,351,137 | $80.47 | $189,195,994.39 | |
| 8/14/2015 | Reeve B Waud | Director | Sell | 2,400,001 | $80.47 | $193,128,080.47 | |
| 8/14/2015 | Waud Capital Partners Ii, L.L. | Major Shareholder | Sell | 1,635,457 | $80.47 | $131,605,224.79 | |
| 4/2/2015 | Joey A Jacobs | CEO | Sell | 24,277 | $70.06 | $1,700,846.62 | |
| 3/16/2015 | Robert Walton Swinson | Major Shareholder | Sell | 5,981 | $69.58 | $416,157.98 | |
| 3/13/2015 | Brent Turner | Major Shareholder | Sell | 11,779 | $69.68 | $820,760.72 | |
| 2/19/2015 | David M Duckworth | CFO | Sell | 9,504 | $62.31 | $592,194.24 | |
| 2/19/2015 | Ronald Morgan Fincher | COO | Sell | 10,703 | $62.50 | $668,937.50 | |
| 2/18/2015 | Christopher L Howard | EVP | Sell | 9,378 | $62.75 | $588,469.50 | |
| 12/8/2014 | Robert Walton Swinson | Major Shareholder | Sell | 2,500 | $64.25 | $160,625.00 | |
| 11/6/2014 | Danny E Carpenter | Major Shareholder | Sell | 9,460 | $60.82 | $575,357.20 | |
| 11/3/2014 | Brent Turner | Major Shareholder | Sell | 35,167 | $60.18 | $2,116,350.06 | |
| 11/3/2014 | Bruce A Shear | Chairman | Sell | 25,000 | $59.12 | $1,478,000.00 | |
| 11/3/2014 | Christopher L Howard | EVP | Sell | 29,245 | $59.94 | $1,752,945.30 | |
| 11/3/2014 | Joey A Jacobs | CEO | Sell | 133,087 | $59.95 | $7,978,565.65 | |
| 11/3/2014 | Ronald Morgan Fincher | COO | Sell | 29,695 | $60.42 | $1,794,171.90 | |
| 8/25/2014 | William Grieco | Director | Sell | 4,522 | $50.67 | $229,129.74 | |
| 8/21/2014 | William Grieco | Director | Sell | 7,000 | $50.33 | $352,310.00 | |
| 8/13/2014 | David M Duckworth | CFO | Sell | 1,400 | $48.79 | $68,306.00 | |
| 8/13/2014 | Ronald Morgan Fincher | COO | Sell | 2,489 | $48.00 | $119,472.00 | |
| 7/29/2014 | Christopher L Howard | EVP | Sell | 1,156 | $51.01 | $58,967.56 | |
| 7/29/2014 | Jack E Polson | Major Shareholder | Sell | 4,000 | $50.34 | $201,360.00 | |
| 6/4/2014 | Ronald Morgan Fincher | COO | Sell | 4,442 | $47.68 | $211,794.56 | |
| 5/2/2014 | Brent Turner | major shareholder | Sell | 24,595 | $45.00 | $1,106,775.00 | |
| 5/2/2014 | Christopher Howard | EVP | Sell | 11,536 | $40.76 | $470,207.36 | |
| 5/2/2014 | Joey Jacobs | CEO | Sell | 19,291 | $45.00 | $868,095.00 | |
| 5/1/2014 | Norman King Carter III | major shareholder | Sell | 10,896 | $42.04 | $458,067.84 | |
| 4/29/2014 | Norman King Carter III | major shareholder | Sell | 30,000 | $41.73 | $1,251,900.00 | |
| 4/9/2014 | Karen Marie Prince | major shareholder | Sell | 5,579 | $44.09 | $245,978.11 | |
| 3/14/2014 | Bruce Shear | Chairman | Sell | 38,069 | $46.10 | $1,754,980.90 | |
| 3/14/2014 | David Duckworth | CFO | Sell | 7,540 | $45.73 | $344,804.20 | |
| 3/14/2014 | William Grieco | Director | Sell | 5,000 | $46.29 | $231,450.00 | |
| 2/3/2014 | Norman King Carter III | major shareholder | Sell | 20,000 | $51.08 | $1,021,600.00 | |
| 1/31/2014 | Karen Marie Prince | major shareholder | Sell | 10,000 | $51.42 | $514,200.00 | |
| 1/29/2014 | Norman King Carter III | major shareholder | Sell | 30,000 | $51.79 | $1,553,700.00 | |
| 11/1/2013 | Norman King Carter III | Major Shareholder | Sell | 29,600 | $42.20 | $1,249,120.00 | |
| 10/29/2013 | Karen Marie Prince | Major Shareholder | Sell | 20,000 | $39.14 | $782,800.00 | |
| 8/1/2013 | Karen Marie Prince | Major Shareholder | Sell | 28,000 | $35.80 | $1,002,400.00 | |
| 7/31/2013 | Norman King Carter III | Major Shareholder | Sell | 20,000 | $35.30 | $706,000.00 | |
| 7/29/2013 | Karen Marie Prince | Major Shareholder | Sell | 22,000 | $34.26 | $753,720.00 | |
| 6/10/2013 | William Grieco | Director | Sell | 13,000 | $34.77 | $452,010.00 | |
| 5/15/2013 | Bruce A Shear | Chairman | Sell | 10,000 | $34.50 | $345,000.00 | |
| 5/10/2013 | William Grieco | Director | Sell | 15,000 | $33.34 | $500,100.00 | |
| 5/9/2013 | David M Duckworth | CFO | Sell | 4,000 | $33.20 | $132,800.00 | |
| 5/7/2013 | Ronald Morgan Fincher | COO | Sell | 2,804 | $32.78 | $91,915.12 | |
| 12/24/2012 | Brent Turner | Major Shareholder | Sell | 10,551 | $21.60 | $227,901.60 | |
| 12/24/2012 | Bruce A Shear | Chairman | Sell | 7,500 | $21.60 | $162,000.00 | |
| 12/24/2012 | Christopher L Howard | EVP | Sell | 8,774 | $21.60 | $189,518.40 | |
| 12/24/2012 | Joey A Jacobs | CEO | Sell | 39,927 | $21.60 | $862,423.20 | |
| 12/24/2012 | Reeve B Waud | Director | Sell | 425,591 | $21.60 | $9,192,765.60 | |
| 12/24/2012 | Ronald Morgan Fincher | COO | Sell | 8,909 | $21.60 | $192,434.40 | |
(Data available from 1/1/2013 forward)
Headline Trends for Acadia Healthcare Company (NASDAQ:ACHC)
Latest Headlines for Acadia Healthcare Company (NASDAQ:ACHC)
| Source: |
|
| Date | Headline |
|---|
 | Acadia Healthcare Company, Inc. (ACHC) Now Covered by Analysts at BMO Capital Markets
www.americanbankingnews.com - October 16 at 7:28 PM |
| Acadia Healthcare Company, Inc. (ACHC) Lowered to Sell at Zacks Investment Research
www.americanbankingnews.com - October 14 at 6:28 PM |
 | Acadia Healthcare Company Becomes Oversold - Nasdaq
www.nasdaq.com - October 13 at 8:27 PM |
| Short Interest in Acadia Healthcare Company, Inc. (ACHC) Drops By 14.3%
www.americanbankingnews.com - October 13 at 1:32 AM |
| Acadia Healthcare Company, Inc. (ACHC) PT Set at $60.00 by Jefferies Group LLC
www.americanbankingnews.com - October 12 at 10:38 PM |
 | Specialized Health Services Stock Performance Review -- Acadia Healthcare, DaVita, HealthSouth, and MEDNAX - PR Newswire (press release)
www.prnewswire.com - October 12 at 3:43 PM |
| Jefferies Group Weighs in on Acadia Healthcare Company, Inc.'s FY2017 Earnings (ACHC)
www.americanbankingnews.com - October 12 at 9:34 AM |
| Acadia Healthcare Company, Inc. (ACHC) Receives Consensus Recommendation of "Buy" from Analysts
www.americanbankingnews.com - October 12 at 6:14 AM |
| Critical Review: Acadia Healthcare (ACHC) and The Competition
www.americanbankingnews.com - October 11 at 12:24 PM |
| Acadia Healthcare Company (ACHC) Shares Cross Below 200 DMA
www.nasdaq.com - October 9 at 4:34 PM |
| Acadia Healthcare Company, Inc. (ACHC) Expected to Announce Earnings of $0.66 Per Share
www.americanbankingnews.com - October 2 at 8:12 PM |
| Select Medical Holdings Corporation (SEM) versus Acadia Healthcare (ACHC) Head-To-Head Review
www.americanbankingnews.com - September 25 at 6:32 AM |
| Comparing Acadia Healthcare (ACHC) & LifePoint Health (LPNT)
www.americanbankingnews.com - September 24 at 8:43 AM |
| Analyzing Acadia Healthcare (ACHC) and Its Peers
www.americanbankingnews.com - September 17 at 6:12 PM |
| Acadia Healthcare Company, Inc. (ACHC) Receives Average Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - September 17 at 6:38 AM |
| $729.80 Million in Sales Expected for Acadia Healthcare Company, Inc. (ACHC) This Quarter
www.americanbankingnews.com - September 16 at 1:10 PM |
| Acadia Healthcare (ACHC) & Its Competitors Head to Head Review
www.americanbankingnews.com - September 13 at 12:38 AM |
| 4 Healthy Stocks from an Ailing Hospital Industry - Nasdaq
www.nasdaq.com - September 5 at 3:40 PM |
 | 4 Healthy Stocks from an Ailing Hospital Industry
finance.yahoo.com - September 5 at 3:40 PM |
| Acadia Healthcare (ACHC) Up 42% This Year: Is Upside Left? - Nasdaq
www.nasdaq.com - September 1 at 3:43 PM |
| Acadia Healthcare (ACHC) Up 42% This Year: Is Upside Left?
finance.yahoo.com - September 1 at 3:43 PM |
 | Stocks Under Scanner in the Specialized Health Services Space -- Acadia Healthcare, DaVita, HealthSouth, and MEDNAX
www.marketwatch.com - September 1 at 1:22 AM |
| Stocks Under Scanner in the Specialized Health Services Space -- Acadia Healthcare, DaVita, HealthSouth, and ... - PR Newswire (press release)
www.prnewswire.com - August 31 at 3:22 PM |
| Acadia Healthcare to Present at Baird and Wells Fargo Healthcare Conferences
finance.yahoo.com - August 30 at 3:25 PM |
| Short Interest in Acadia Healthcare Company, Inc. (ACHC) Drops By 5.7%
www.americanbankingnews.com - August 27 at 2:22 AM |
| Insiders Roundup: Walmart, General Electric - Nasdaq
www.nasdaq.com - August 26 at 3:19 PM |
| Head-To-Head Survey: Acadia Healthcare (ACHC) and Quest Diagnostics (DGX)
www.americanbankingnews.com - August 25 at 10:06 PM |
| Acadia Healthcare Co Inc (ACHC) CEO Joey A Jacobs Sold $25.3 million of Shares
finance.yahoo.com - August 23 at 8:55 AM |
| Acadia Healthcare Company, Inc. (ACHC) Given Average Rating of "Buy" by Brokerages
www.americanbankingnews.com - August 23 at 6:32 AM |
| Acadia Healthcare Company, Inc. (ACHC) President Brent Turner Sells 206,252 Shares
www.americanbankingnews.com - August 22 at 10:20 PM |
| Acadia Healthcare Company, Inc. (ACHC) Director Sells $49,882,761.75 in Stock
www.americanbankingnews.com - August 22 at 7:16 PM |
| Insider Selling: Acadia Healthcare Company, Inc. (ACHC) EVP Sells 53,713 Shares of Stock
www.americanbankingnews.com - August 22 at 7:16 PM |
| Joey A. Jacobs Sells 500,000 Shares of Acadia Healthcare Company, Inc. (ACHC) Stock
www.americanbankingnews.com - August 22 at 7:16 PM |
| Acadia Healthcare Company, Inc. (ACHC) COO Ronald Morgan Fincher Sells 80,000 Shares
www.americanbankingnews.com - August 22 at 7:16 PM |
| Acadia Healthcare Co., Inc. breached its 50 day moving average in a Bearish Manner : ACHC-US : August 18, 2017
finance.yahoo.com - August 18 at 3:22 PM |
 | Acadia Healthcare (ACHC) Announces Secondary Offering of 2.8M Shares of Common Stock
www.streetinsider.com - August 17 at 3:43 PM |
| ABIO To Report Data In Q1; IOVA Fired Up, PMD In Iowa, VRX All Cleared - Nasdaq
www.nasdaq.com - August 17 at 1:28 AM |
 | Acadia Healthcare Company, Inc. Announces Secondary Offering of 2825016 Shares of Common Stock by Selling ... - Business Wire (press release)
www.businesswire.com - August 17 at 1:28 AM |
 | BRIEF-Acadia Healthcare Company, Inc. Announces secondary offering of 2.8 m;n shares of common stock by selling stockholders
www.reuters.com - August 16 at 8:25 PM |
 | Why Diligence Matters: Don't Buy Acadia Healthcare's Roll-Up
seekingalpha.com - August 16 at 8:25 PM |
| Acadia Healthcare Company, Inc. Announces Secondary Offering of 2,825,016 Shares of Common Stock by Selling Stockholders
finance.yahoo.com - August 16 at 8:25 PM |
| See what the IHS Markit Score report has to say about Acadia Healthcare Company Inc.
finance.yahoo.com - August 16 at 3:23 PM |
| Not Buying Acadia Healthcare's Roll-Up Story
finance.yahoo.com - August 16 at 3:23 PM |
| ETFs with exposure to Acadia Healthcare Co., Inc. : August 15, 2017
finance.yahoo.com - August 15 at 3:33 PM |
| Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Director Sells $103,420.00 in Stock
www.americanbankingnews.com - August 14 at 11:30 PM |
| Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Sees Significant Decrease in Short Interest
www.americanbankingnews.com - August 12 at 3:08 AM |
 | Mount Carmel-Acadia psychiatric hospital will go in next to shuttered Fort Rapids Water Park - Columbus Business First
www.bizjournals.com - August 10 at 4:51 PM |
| Christopher L. Howard Sells 16,762 Shares of Acadia Healthcare Company, Inc. (ACHC) Stock
www.americanbankingnews.com - August 4 at 7:52 PM |
| Insider Selling: Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Insider Sells 2,891 Shares of Stock
www.americanbankingnews.com - August 2 at 8:52 PM |
| Cantor Fitzgerald Analysts Decrease Earnings Estimates for Acadia Healthcare Company, Inc. (NASDAQ:ACHC)
www.americanbankingnews.com - August 2 at 4:18 PM |
Acadia Healthcare Company (ACHC) Chart for Tuesday, October, 17, 2017
